Pharmaceutical companies behind blood thinner Xarelto reached a $775 million settlement in 25,000 lawsuits alleging patients were not adequately warned about the risks of life-threatening complications.
Bottles of Xarelto prescription pharmaceuticals photographed in a pharmacy in Remington, Virginia, on Feb. 26, 2019.Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.Associated Press
Xarelto is the brand name for the drug rivaroxaban. Among its uses is treatment and prevention of blood clots in the leg or lung and prevention of strokes in people with irregular heartbeats. Heavily advertised on television, it was hawked in a widely seen 2015 ad featuring comedian Kevin Nealon, golfer Arnold Palmer and NASCAR driver Brian Vickers.
"There is no admission of liability, and we remain steadfast that the claims raised in the litigation contradict years of scientific data and the U.S. Food and Drug Administration's repeated confirmation of Xarelto's safety and efficacy," Sarah Freeman, a spokeswoman for Janssen Pharmaceuticals said in an emailed statement.
"It may have taken more than four years and six separate trials but litigation like this is an important way for consumers to have a voice in matters of drug safety," lead plaintiff attorney Brian Barr said in the release.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bayer, J&J settle blood thinner Xarelto litigation for $775 millionBayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed.
Read more »
Bayer, J&J settle U.S. Xarelto litigation for $775 millionBayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsu...
Read more »
Sackler Family Actively Trying to Resolve Purdue Pharma LawsuitsMembers of the Sackler family who own OxyContin maker Purdue Pharmahave become more involved in settlement talks to resolve the company’s share of lawsuits accusing drug makers of helping spark the opioid crisis.
Read more »
Here's how Snap is pitching big pharma advertisers to peel them away from FacebookTo win big pharmaceutical advertisers, Snap is positioning itself as a friendlier social network than Facebook and Twitter.
Read more »
Former DEA official now working for Oxycontin maker Purdue PharmaEXCLUSIVE: A former senior DEA official who testified before Congress on the government's efforts to stop the opioid epidemic is now working for Oxycontin maker Purdue Pharma
Read more »
OxyContin maker Purdue agrees to settle Oklahoma opioid case: sourcePurdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusin...
Read more »
Some Sacklers Suspend Charity Donations Amid Opioid LawsuitsCertain members of the Sackler family, which owns prescription opioid maker Purdue Pharma, are suspending new charitable donations around the world as some recipients of the family’s philanthropy reconsider ties.
Read more »
A little-known practice in the pharma industry is under threat, and a new memo reveals how the companies that rely on it are bracing for changeCVS Health is asking drugmakers not to increase the total cost of their drugs if rebates go away, according to a letter obtained by Business Insider.
Read more »